Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-3464PMID 17510384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.

  2006cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations

  2005cited by this paper
• Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling

  2005cited by this paper
• Aberrant methylations in cancer cells: Where do they come from?

  2005cited by this paper
• Aberrant methylation of Reprimo in human malignancies

  2005cited by this paper
• The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.

  2005cited by this paper
• Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

  2004cited by this paper
• CpG island methylator phenotype in cancer

  2004cited by this paper
• Focus on hepatocellular carcinoma.

  2004cited by this paper
• Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.

  2004cited by this paper
• Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

  2004cited by this paper
• Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

  2003cited by this paper
• Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

  2003cited by this paper
• The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells.

  2003cited by this paper
• Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma

  2003cited by this paper
• Short Communication The Tumor Suppressor Gene 14-3-3 Is Commonly Methylated in Normal and Malignant Lymphoid Cells

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• DNA methylation and environmental exposures in human hepatocellular carcinoma.

  2002influential reference
• Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma.

  2002cited by this paper
• Epigenetic variation and human disease.

  2002cited by this paper
• Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.

  2002cited by this paper
• Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis

  2002cited by this paper
• Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis.

  2001cited by this paper
• SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity

  2001cited by this paper
• Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia

  2000cited by this paper
• Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma

  2000cited by this paper
• Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma

  2000cited by this paper
• Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.

  2000cited by this paper
• Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection.

  1999cited by this paper
• β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection

  1999cited by this paper
• p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma

  1999cited by this paper
• Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.

  1999cited by this paper
• p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma.

  1999cited by this paper
• Distinct methylation pattern and microsatellite instability in sporadic gastric cancer

  1999cited by this paper
• Genetic instabilities in human cancers

  1998cited by this paper
• COBRA: a sensitive and quantitative DNA methylation assay.

  1997cited by this paper
• p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

  1995cited by this paper
• Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

  1993cited by this paper
• Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.

  1992cited by this paper
• A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

  1992cited by this paper
• Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma

  1992cited by this paper
• Tumorigenesis and Neoplastic Progression Epigenetic Instability and Chromosomal Instability in Hepatocellular Carcinoma

  year unknowncited by this paper

• Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges

  2024cites this paper
• Measuring the differential expression of the major hypermethylated tumor suppressor genes in tissues of primary hepatocellular carcinoma

  2024cites this paper
• Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma

  2022cites this paper
• Advances in molecular classification and precision oncology in hepatocellular carcinoma.

  2020cites this paper
• Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma

  2020cites this paper
• Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers

  2020cites this paper
• LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype

  2019cites this paper
• SFRP2 Promoter Methylation Analysis in Tumor Tissue, Stool, and Plasma DNA of Patients with Colorectal Cancer

  2019cites this paper
• Hepatocellular Carcinomas With Mutational Activation of Beta Catenin Require Choline and can be Detected by Positron Emission Tomography.

  2019cites this paper
• Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy

  2018cites this paper
• Mechanisms of Disease: The Damaged Genome in HCC

  2018cites this paper
• Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance

  2018cites this paper
• Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors

  2017cites this paper
• Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.

  2017cites this paper
• Die Wirkung von Curcumin in kindlichen soliden Tumoren am Beispiel des hepatozellulären Karzinoms, des Hepatoblastoms und des Rhabdomyosarkoms

  2017cites this paper
• Application of Clinical Bioinformatics

  2016cites this paper
• Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma

  2016cites this paper
• Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations

  2016cites this paper
• Promoter hypermethylation mediates the down-regulated expression of ADAMTS 9 and is associated with the prognosis in hepatocellular carcinoma

  2016cites this paper
• Molecular Profiling of Human Hepatocellular Carcinoma

  2016cites this paper
• Heterogeneity of Hepatocellular Carcinoma

  2016cites this paper
• Disruption of TGF-β Pathway and Epithelial-Mesenchymal Transition Phenotype

  2015cites this paper
• TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma

  2015cites this paper
• Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival

  2015cites this paper
• Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma

  2015cites this paper
• Hepatic DNA Methylation Is Affected by Hepatocellular Carcinoma Risk in Patients with and without Hepatitis Virus

  2015cites this paper
• Studies on Epigenetic Changes Involved in HCV Mediated Hepatocarcinogenesis

  2015cites this paper
• Hnf4α and Choline Metabolism Role in β-catenin Activated Liver Carcinogenesis

  2015cites this paper
• DNA markers in molecular diagnostics for hepatocellular carcinoma

  2014cites this paper
• Identification of Epigenetically Inactivated Genes in Human Hepatocellular Carcinoma by Integrative Analyses of Methylation Profiling and Pharmacological Unmasking

  2014cites this paper
• Exploration of liver cancer genomes

  2014cites this paper
• Recent Advancements in Comprehensive Genetic Analyses for Human Hepatocellular Carcinoma

  2013cites this paper
• Reactive Oxygen Species Induce Epigenetic Instability through the Formation of 8-Hydroxydeoxyguanosine in Human Hepatocarcinogenesis

  2013cites this paper
• Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma

  2013cites this paper
• Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma

  2013cites this paper
• Demethylation of Cancer/Testis Antigens and CpG ODN Stimulation Enhance Dendritic Cell and Cytotoxic T Lymphocyte Function in a Mouse Mammary Model

  2013influential citation
• Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors

  2012cites this paper
• Gender Differences in the Livers of Patients with Hepatocellular Carcinoma and Chronic Hepatitis C Infection

  2012cites this paper
• Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma

  2012cites this paper
• Genomics of Hepatocellular Carcinoma

  2012cites this paper
• Hepatitis B Virus-Associated Hepatocellular Carcinoma from India: Role of Viral Genotype and Mutations in CTNNB1 (Beta-Catenin) and TP53 Genes

  2011cites this paper
• Gene Expression and Mutation Assessment Provide Clues of Genetic and Epigenetic Mechanisms in Liver Tumors of Oxazepam-Exposed Mice

  2011cites this paper
• Expansion of CpG methylation in the SFRP2 promoter region during colorectal tumorigenesis.

  2011cites this paper
• The Effects of Polo-like Kinase 4 on Chromosomal Stability, Cell Migration and Tumourigenesis

  2011cites this paper
• From liver cirrhosis to HCC

  2011cites this paper
• Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review

  2011cites this paper
• Glutamine Synthetase Immunostaining Correlates with Pathologic Features of Hepatocellular Carcinoma and Better Survival after Radiofrequency Thermal Ablation

  2010cites this paper
• Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.

  2010cites this paper
• Molecular Mechanisms of Hepatocellular Carcinoma: Insights to Therapy

  2009cites this paper
• A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis.

  2009cites this paper
• A Preliminary Operational Classification System for Nonmutagenic Modes of Action for Carcinogenesis

  2009cites this paper
• Promoter Methylation in the Genesis of Gastrointestinal Cancer

  2009cites this paper
• Prognostic Implications of and Relationship Between CpG Island Hypermethylation and Repetitive DNA Hypomethylation in Hepatocellular Carcinoma

  2009cites this paper
• 2007 Publications of the Baylor Health Care System Medical and Scientific Staff

  2008cites this paper
• Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma

  2008cites this paper
• High-dimensional biology to comprehend hepatocellular carcinoma

  2008cites this paper
• Wnt signaling in liver cancer.

  2008cites this paper
• Hepatocellular carcinoma: epidemiology and clinical aspects.

  2008cites this paper
• DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.

  2008influential citation
• Viral hepatocarcinogenesis: from infection to cancer

  2008cites this paper
• Molecular pathogenesis of hepatocellular carcinoma

  2007cites this paper